Treatment disparities in acute coronary syndromes, heart failure, and kidney disease

Contributions to Nephrology

Volumn 171, Issue , 2011, Pages 68-73

  McCullough, Peter A ^a   Maynard, Robert C ^a  

^a St John Providence Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; HEALTH CARE DISPARITY; HEART FAILURE; HUMAN; KIDNEY DISEASE; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; HEALTHCARE DISPARITIES; HEART FAILURE; HUMANS; KIDNEY DISEASES; TREATMENT OUTCOME;

EID: 84925936273     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000327230     Document Type: Article

References (22)

1. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM, CRUSADE Investigators: Utilization of early invasive management strategies for highrisk patients with non- ST- segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292:2096-2104. (Pubitemid 39435100)
2. Fonarow GC: Acute decompensated heart failure: challenges and opportunities. Rev Cardiovasc Med 2007;8(suppl 5):S3-S12.
3. Heart Failure Society Of America: Evaluation and management of patients with acute decompensated heart failure. J Card Fail 2006;12: e86-e103.
4. Yerkey MW, Kernis SJ, Franklin BA, Sandberg KR, McCullough PA: Renal dysfunction and acceleration of coronary disease. Heart 2004;90:961-966. (Pubitemid 39005960)
5. McCullough PA: Treatment disparities in patients with acute coronary syndromes and kidney disease. Eur Heart J 2009;30:526-527.
6. Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S: Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta- analysis of randomized trials. JAMA 2005;293:2908-2917. (Pubitemid 41029145)
7. Wong JA, Goodman SG, Yan RT, Wald R, Bagnall AJ, Welsh RC, Wong GC, Kornder J, Eagle KA, Steg PG, Yan AT, Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE) Investigators: Temporal management patterns and outcomes of non- ST elevation acute coronary syndromes in patients with kidney dysfunction. Eur Heart J 2009; 30:549-557.
8. Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T, SWEDEHEART: Influence of renal function on the effects of early revascularization in non- ST- elevation myocardial infarction: data from the Swedish Web- System for Enhancement and Development of Evidence- Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation 2009; 120:851-858.
9. McCullough PA, Verrill T: Lessons learned from acute myocardial infarction in patients with chronic kidney disease. J Intern Med 2010;268:38-39.
10. McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury N, Weaver WD, Sandberg KR, McCord J: Emergency evaluation of chest pain in patients with advanced kidney disease. Arch Intern Med. 2002;162:2464-2468. (Pubitemid 35340463)
11. Keeley EC, Kadakia R, Soman S, Borzak S, McCullough PA: Analysis of long- term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003;92:509-514. (Pubitemid 37013400)
12. McCullough PA: Cardiovascular disease in chronic kidney disease from a cardiologist's perspective. Curr Opin Nephrol Hypertens 2004;13:591-600. (Pubitemid 39506906)
13. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD: Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (R.E.A.C.H.) Study. J Am Coll Cardiol 2002;39:60-69. (Pubitemid 34059862)
14. McCullough PA: Cardiorenal syndromes: pathophysiology to prevention. Int J Nephrol 2010;2011:762590
15. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML, APPROACH Investigators: The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004;44:1587-1592. (Pubitemid 39369790)
16. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-1295. (Pubitemid 39258422)
17. McCullough PA, Ahmad A: Cardiorenal syndromes. World J Cardiol 2011;3:1-9.
18. Wase A, Basit A, Nazir R, Jamal A, Shah S, Khan T, Mohiuddin I, White C, Saklayen M, McCullough PA: Impact of chronic kidney disease upon survival among implantable cardioverter- defibrillator recipients. J Interv Card Electrophysiol 2004;11: 199-204. (Pubitemid 40949506)
19. McCullough PA, Wase A: Do implantable cardioverter- defibrillators improve survival in dialysis patients after cardiac arrest? Nat Clin Pract Nephrol 2006;2:70-71. (Pubitemid 43355211)
20. Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF: Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta- analysis. Clin J Am Soc Nephrol 2009;4: 542-551.
21. Ezekowitz JA, McAlister FA: Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 2009;30:469-477.
22. Pitt B, PEARL- HF Investigators: Multicenter, randomized, doubleblind, placebo- controlled, parallelgroup, multiple- dose study to evaluate the effects of RLY5016 in heart failure patients. ESC Scientific Session, Stockholm, 2010.